Supercharging Immune Cells May Help Control HIV Long-Term

Researchers repurposed CAR-T cell therapy for HIV in an early trial and saw encouraging results.

Two participants stayed at undetectable viral levels after a single infusion and were able to stop antiretroviral drugs for about a year to nearly two years.

The findings suggest CAR-T could help control HIV without daily medication and may point to a functional cure.

Experts say this approach could be more scalable than stem cell transplantation, a rare route that has achieved cure-like outcomes in the past.